Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Laura Elizabeth Miller"'
Autor:
Dawn J Storey, Karen Smith, Gregory Naylor, Nicola Williams, Richard H. Wilson, Anne Jane McKillop, Mary G. Dunn, Alec McDonald, Janet Graham, Christine Crearie, Liz Radford, Aqilah Othman, N. MacLeod, Paul Westwood, Tareq Abdullah, Gillian McGaffin, Nazia Mohammed, Wendy Campbell, Jocelyn Saunders, Laura Elizabeth Miller
Publikováno v:
Journal of Clinical Oncology. 38:93-93
93 Background: The fluoropyrimidines (FP), 5-Fluorouracil (5-FU) and capecitabine are a mainstay of colorectal cancer (CRC) treatment. Dihydropyrimidine dehydrogenase (DPYD), an enzyme encoded by the DPYD gene, is the initial and rate-limiting step i
Autor:
Thomas F. O'Brien, Jeffrey B Gibson, Edward T. Robbins, Robert A. Ramirez, Xinhua Yu, Glenn P. Schoettle, Alim Khandekar, Laura Elizabeth Miller, Samuel G. Robbins, Raymond U. Osarogiagbon, Christopher G. Wang
Publikováno v:
Journal of Thoracic Oncology. 7:1276-1282
Introduction:Pathologic examination of mediastinal lymph nodes (MLNs) after resection of non–small-cell lung cancer is critical in the determination of prognosis and postoperative management. Although systematic nodal dissection is recommended, the
Autor:
Allen Berry, Xinhua Yu, Christopher G. Wang, Raymond U. Osarogiagbon, Thomas F. O'Brien, Robert A. Ramirez, Courtney A. Adair, Laura Elizabeth Miller
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(23)
Purpose Pathologic nodal stage affects prognosis in patients with surgically resected non–small-cell lung cancer (NSCLC). Unlike examination of mediastinal lymph nodes (LNs), which depends on surgical practice, accurate examination of intrapulmonar
Autor:
Christopher G. Wang, Edward T. Robbins, Raymond U. Osarogiagbon, Jeffrey B Gibson, Laura Elizabeth Miller, Srishti Sareen, B. Wolf, Ahmed Y. Javed, Samuel G. Robbins, Matthew P. Smeltzer, Alim Khandekar, Glenn P. Schoettle, Robert A. Ramirez
Publikováno v:
Journal of Clinical Oncology. 31:7569-7569
7569 Background: LN metastasis impairs survival of resectable NSCLC, but routine pathologic nodal staging is suboptimal. We tested the impact of a dual intervention (a surgical specimen collection kit with specific, pre-labeled LN collection cups, to
Autor:
Thomas F. O'Brien, Laura Elizabeth Miller, Raymond U. Osarogiagbon, Christopher G. Wang, Courtney A. Adair, Allen Berry, Robert A. Ramirez
Publikováno v:
Journal of Clinical Oncology. 30:7072-7072
7072^ Background: Lymph node (LN) status is the most important prognostic determinant after resection of lung cancer. 18% of a SEER cohort and 12% of a Memphis cohort had no LNs examined (pNx). Patients with pNx have inferior survival to T-category m
Autor:
Christopher G. Wang, Jeffrey B Gibson, Thomas F. O'Brien, Laura Elizabeth Miller, Glenn P Schoettle, Alim Khandekar, Robert A. Ramirez, Edward T. Robbins, Samuel G. Robbins, Raymond U. Osarogiagbon
Publikováno v:
Journal of Clinical Oncology. 30:e17531-e17531
e17531^ Background: The number of LNs examined following lung cancer resection has prognostic value. The International Association for the Study of Lung Cancer (IASCLC) recommends a minimum of 6 LNs and other series have recommended greater than 11.
Autor:
Thomas F. O'Brien, Raymond U. Osarogiagbon, H. Cole, Alva Bowen Weir, Robert A. Ramirez, Laura Elizabeth Miller, Christopher G. Wang
Publikováno v:
Journal of Clinical Oncology. 29:e17516-e17516
e17516 Background: LN metastasis profoundly affects prognosis of patients with resectable NSCLC. Variation in LN examination practice may impact staging accuracy. Evidence from other cancers sugges...
Autor:
A. Farooq, M. Ul-Haq, Thomas F. O'Brien, Christopher G. Wang, Allen Berry, Alva Bowen Weir, Robert A. Ramirez, H. Cole, Raymond U. Osarogiagbon, Laura Elizabeth Miller, David M. Spencer, J. W. Allen
Publikováno v:
Journal of Clinical Oncology. 29:7054-7054
7054 Background: Lymph node (LN) stage is the major prognostic factor in resectable lung cancer. Yet 16-18% of U.S. lung cancer resections have no examined LN (pNx). These patients are usually trea...
Autor:
Thomas F. O'Brien, J. W. Allen, H. Cole, Laura Elizabeth Miller, Rafael Arteta-Bulos, M. Ul-Haq, Raymond U. Osarogiagbon, Alva Bowen Weir, Robert A. Ramirez, A. Farooq, Christopher G. Wang, M. T. Chi
Publikováno v:
Journal of Clinical Oncology. 29:e17513-e17513
e17513 Background: The AJCC 7 lung cancer staging system was developed from a large international dataset. Unlike AJCC 6, AJCC 7 was less insistent on surgical staging, which is more accurate than clinical staging. AJCC 7 is more elaborate, moved som